Sagimet Biosciences Inc. - Series A Common Stock, par value $0.0001 per share (SGMT)

Historical Holders from Q3 2023 to Q3 2025

Symbol
SGMT on Nasdaq
CUSIP
786700104
Type / Class
Equity / Series A Common Stock, par value $0.0001 per share
Shares outstanding
31.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
12.5M
Holdings value
$85.9M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
71
Number of buys
40
Number of sells
-25
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sagimet Biosciences Inc. - Series A Common Stock, par value $0.0001 per share (SGMT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AP11 Ltd 4.9% -10% $4.78M -$477K 1.5M -9.07% AP11 Limited Jun 24, 2025
Woodline Partners LP 4.8% -43.8% $10.3M -$7.21M 1.5M -41.2% Woodline Partners LP Sep 30, 2025
Blue Owl Capital Holdings LP 4.32% $3.06M 1.32M Blue Owl Capital Holdings LP Dec 31, 2024

Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, par value $0.0001 per share (SGMT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 12.5M $85.9M +$6.75M $6.86 71
2025 Q2 11.7M $89M +$3.49M $7.62 67
2025 Q1 13.8M $44.9M -$15.2M $3.26 69
2024 Q4 17.5M $78.8M -$8.86M $4.50 66
2024 Q3 19.7M $54.4M -$7.22M $2.77 63
2024 Q2 20.9M $71.6M -$7.44M $3.42 80
2024 Q1 22.6M $123M +$44M $5.42 81
2023 Q4 14.4M $76.1M -$8.91M $5.42 51
2023 Q3 15.6M $130M +$130M $8.80 47